AKBA Akebia Therapeutics, Inc.

Nasdaq Pharmaceutical Preparations DE CIK: 0001517022
AI RATING
HOLD
62% Confidence

Investment Thesis

Akebia demonstrates strong revenue growth (+47.5% YoY) and robust cash generation (FCF margin of 28.7%), but profitability remains challenged with negative net income despite positive operating income. The company maintains adequate liquidity with a 1.55x current ratio and substantial cash reserves ($184.8M), though elevated leverage (1.48x Debt/Equity) and negative returns on equity (-16.4%) signal ongoing operational pressures.

Strengths

  • + Strong topline growth of 47.5% YoY indicating robust commercial execution
  • + Exceptional free cash flow generation at $67.7M with 28.7% FCF margin showing strong cash conversion
  • + Solid liquidity position with $184.8M cash and 1.55x current ratio providing financial flexibility

Risks

  • ! Persistent net losses (-$5.3M) and negative net margin (-2.3%) despite revenue growth suggests margin pressure or one-time charges
  • ! Elevated leverage at 1.48x Debt/Equity with long-term debt of $48.2M relative to small equity base of $32.6M
  • ! Negative returns on equity (-16.4%) and ROA (-1.4%) indicate inefficient asset utilization and value destruction for shareholders

Key Metrics to Watch

Financial Metrics

Revenue
236.2M
Net Income
-5.3M
EPS (Diluted)
$-0.02
Free Cash Flow
67.7M
Total Assets
376.6M
Cash
184.8M

Profitability Ratios

Gross Margin N/A
Operating Margin 9.9%
Net Margin -2.3%
ROE -16.4%
ROA -1.4%
FCF Margin 28.7%

Balance Sheet & Liquidity

Current Ratio
1.55x
Quick Ratio
1.46x
Debt/Equity
1.48x
Debt/Assets
91.3%
Interest Coverage
N/A
Long-term Debt
48.3M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-03-19T17:48:34.103109 | Data as of: 2025-12-31 | Powered by Claude AI